Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Nov 2021
Historique:
received: 26 04 2021
revised: 02 07 2021
accepted: 03 07 2021
pubmed: 19 7 2021
medline: 27 10 2021
entrez: 18 7 2021
Statut: ppublish

Résumé

The rise of the resistance of the malaria parasite to the currently approved therapy urges the discovery and development of new efficient agents. Previously we have demonstrated that harmicines, hybrid compounds composed from β-carboline alkaloid harmine and cinnamic acid derivatives, linked via either triazole or amide bond, exert significant antiplasmodial activity. In this paper, we report synthesis, antiplasmodial activity and cytotoxicity of expanded series of novel triazole- and amide-type harmicines. Structure-activity relationship analysis revealed that amide-type harmicines 27, prepared at N-9 of the β-carboline core, exhibit superior potency against both erythrocytic stage of P. falciparum and hepatic stages of P. berghei. Notably, harmicine 27a, m-(trifluoromethyl)cinnamic acid derivative, exhibited the most favourable selectivity index (SI = 1105). Molecular dynamics simulations revealed the ATP binding site of P. falciparum heat shock protein 90 as a druggable binding location, confirmed the usefulness of the harmine's N-9 substitution and identified favourable N-H … π interactions involving Lys45 and the aromatic phenyl unit in the attached cinnamic acid fragment as crucial for the enhanced biological activity. Thus, those compounds were identified as promising and valuable leads for further derivatization in the search of novel, more efficient antiplasmodial agents.

Identifiants

pubmed: 34274829
pii: S0223-5234(21)00536-5
doi: 10.1016/j.ejmech.2021.113687
pii:
doi:

Substances chimiques

Amides 0
Antimalarials 0
HSP90 Heat-Shock Proteins 0
Indole Alkaloids 0
Protozoan Proteins 0
Triazoles 0
harmicine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113687

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Marina Marinović (M)

University of Zagreb Faculty of Pharmacy and Biochemistry, A. Kovačića 1, 10000, Zagreb, Croatia.

Goran Poje (G)

University of Zagreb Faculty of Pharmacy and Biochemistry, A. Kovačića 1, 10000, Zagreb, Croatia.

Ivana Perković (I)

University of Zagreb Faculty of Pharmacy and Biochemistry, A. Kovačića 1, 10000, Zagreb, Croatia.

Diana Fontinha (D)

Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal.

Miguel Prudêncio (M)

Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal.

Jana Held (J)

University of Tübingen, Institute of Tropical Medicine, Wilhelmstraße 27, 72074, Tübingen, Germany.

Lais Pessanha de Carvalho (L)

University of Tübingen, Institute of Tropical Medicine, Wilhelmstraße 27, 72074, Tübingen, Germany.

Tana Tandarić (T)

Rudjer Bošković Institute, Division of Organic Chemistry and Biochemistry, Bijenička Cesta 54, 10 000, Zagreb, Croatia.

Robert Vianello (R)

Rudjer Bošković Institute, Division of Organic Chemistry and Biochemistry, Bijenička Cesta 54, 10 000, Zagreb, Croatia.

Zrinka Rajić (Z)

University of Zagreb Faculty of Pharmacy and Biochemistry, A. Kovačića 1, 10000, Zagreb, Croatia. Electronic address: zrajic@pharma.hr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH